Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Lidocaine patch 5%
Trade Name: Lidoderm Patch
Date Designated: 10/24/1995
Orphan Designation: For relief of allodynia (painful hypersensitivity), and chronic pain in postherpetic neuralgia.
Orphan Designation Status: Designated/Approved
Teikoku Pharma USA, Inc.
745-D Camden Ave.
Campbell, California 95008
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Lidocaine patch 5%
Trade Name: Lidoderm Patch
Marketing Approval Date: 03/19/1999
Approved Labeled Indication:
Exclusivity End Date: 03/19/2006 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-